dc.contributor.author |
Schellack, Natalie
|
|
dc.contributor.author |
Padayachee, N.
|
|
dc.contributor.author |
Schellac, G.
|
|
dc.date.accessioned |
2022-10-12T10:19:22Z |
|
dc.date.available |
2022-10-12T10:19:22Z |
|
dc.date.issued |
2021-03-10 |
|
dc.description.abstract |
The global number of deaths due to COVID-19 is almost at the two million mark, with over 35 000 deaths in South Africa. Although there are
hopes of a safe and effective vaccination programme, the increasing number of COVID-19 cases in the country is putting a significant strain
on the healthcare system. Ivermectin, an antiparasitic drug, has been widely published on social media platforms and news outlets as a socalled miracle drug for the treatment of COVID-19. Ivermectin is not registered in SA as a drug for human use, but rather as a veterinary and
agricultural product. Currently, from a small number of randomised controlled trials (RCTs), there does seem to be a signal of evidence for the
use of ivermectin in the management of COVID-19. Pharmacists must, however, remain cognisant of their ethical responsibilities as well as the
applicable regulations that prohibit the procurement and dispensing of any unregistered medicine. |
en_US |
dc.description.department |
Pharmacology |
en_US |
dc.description.uri |
https://medpharm.co.za/about-our-journals/sagp |
en_US |
dc.identifier.citation |
Schellack, N., Padayachee, N., Schellac, G. 2021, 'Ivermectin in the treatment of
COVID-19— friend or foe?', South African General Practitioner, vol. 88, no. 1, pp. 11-14. |
en_US |
dc.identifier.issn |
2706-9613 (print) |
|
dc.identifier.issn |
2706-9621 (online) |
|
dc.identifier.uri |
https://repository.up.ac.za/handle/2263/87647 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Medpharm publications |
en_US |
dc.rights |
© 2021 The Author(s). Open Access article distributed under the terms of the
Creative Commons License [CC BY-NC-ND 4.0]. |
en_US |
dc.subject |
Avermectin |
en_US |
dc.subject |
Ivermectin |
en_US |
dc.subject |
Macrocyclic lactone |
en_US |
dc.subject |
Endectocide |
en_US |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
en_US |
dc.title |
Ivermectin in the treatment of COVID-19-friend or foe? |
en_US |
dc.type |
Article |
en_US |